Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose methoxyflurane vs standard of care for trauma pain in Dutch EMS
2018-001601-82Phase 3Terminated
- Sponsor
- Mundipharma
- Start
- Dec 2018
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in acute pain and Extremity Injuries comparing Low-dose methoxyflurane with Standard of care analgesia (2 arms). Primary endpoint: Change in mean pain intensity over 10 minutes. Started Dec 2018; status: terminated.
02
Drugs
methoxyflurane
03
Conditions
acute painExtremity Injuries
Beyond the preview
Go deeper on 2018-001601-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001601-82.